Get an alert when OXFORD NANOPORE TECHNOLOGIES PLC files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

£200M

-9.5% vs 2023

Net assets

£586M

-8.9% vs 2023

Employees

1,315

+16.1% vs 2023

Profit before tax

-£140M

+6.5% vs 2023

Accounts

2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31 Δ vs prior
Turnover £169,668,000£183,191,000 +8%
Operating profit -£168,609,000-£152,333,000 +9.7%
Profit before tax -£149,768,000-£139,961,000 +6.5%
Net profit -£154,507,000-£146,188,000 +5.4%
Cash £220,536,000£199,517,000 -9.5%
Total assets less current liabilities £687,863,000£630,560,000 -8.3%
Net assets £643,851,000£586,338,000 -8.9%
Equity £643,851,000£586,338,000 -8.9%
Average employees 1,1331,315 +16.1%
Wages £99,197,000£124,538,000 +25.5%
Directors' remuneration £4,834,162£4,835,093 0%

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show . About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -99.4%-83.2%
Net margin -91.1%-79.8%
Return on capital employed -24.5%-24.2%
Gearing (liabilities / total assets) 17.1%21.0%
Current ratio 5.01x4.66x
Interest cover -76.43x-42.73x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 2 times since incorporation

  1. OXFORD NANOPORE TECHNOLOGIES PLC 2021-09-24 → present
  2. OXFORD NANOPORE TECHNOLOGIES LIMITED 2008-05-19 → 2021-09-24
  3. OXFORD NANOLABS LIMITED 2005-03-09 → 2008-05-19

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
Deloitte LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“As at 31 December 2024, the Group had £403.8 million in cash, cash equivalents, and other liquid investments (note 34). In order to assess the going concern assumption, the Directors review the budget periodically. It is invested and agreed as appropriate in response to evolving market conditions. Specifically for the financial statements, the Directors have considered the budget and forecast prepared under the Group’s strategic plan, and the impact of a range of severe, but plausible, downside scenarios, revenue, gross and cash flow. The principal issues and risks considered were: supply chain issues driven by demand, logistics interruptions and heightened geopolitical tension; the impact on revenue due to customer, regulatory and research and development (R&D) delays; and increased costs due to supply chain restrictions, rising wages & salary costs, additional R&D requirements and rising costs of component parts. Under all scenarios, the Group has sufficient funds to maintain trading before taking into account any mitigating actions that the Directors could take. The Directors prepare at least one year from the date of approval of the financial statements on the basis of these reviews, the Directors consider this to be appropriate for the going concern basis to be adopted in preparing these financial statements.”

Group structure

  1. OXFORD NANOPORE TECHNOLOGIES PLC · parent
    1. Oxford Nanopore Diagnostics Limited 100% · UK · R&D support
    2. Oxford Nanopore Technologies, Inc. 100% · USA · R&D and Limited risk distributor
    3. Oxford Nanolabs Limited 100% · UK · R&D
    4. The Genome Foundry Limited 100% · UK · Dormant
    5. Metrichor Limited 100% · UK · R&D support
    6. GK Oxford Nanopore Technologies 100% · Japan · Limited risk distributor
    7. Nanopore Technologies (Hong Kong) Limited 100% · Hong Kong · Holding company
    8. Nanopore Technologies (Shanghai) Co. Limited 100% · China · Limited risk distributor and sales and marketing support
    9. Oxford Nanopore Technologies Singapore PTE Ltd 100% · Singapore · Limited risk distributor and sales and marketing support
    10. Oxford Nanopore Technologies B.V. 100% · The Netherlands · Limited risk distributor and sales and marketing support
    11. Oxford Nanopore Technologies Australia PTY Ltd 100% · Australia · Limited risk distributor and sales and marketing support
    12. Oxford Nanopore Technologies Denmark ApS 100% · Denmark · Sales and marketing support
    13. Oxford Nanopore Technologies SARL 100% · France · Sales and marketing support
    14. Oxford Nanopore Technologies GmbH 100% · Germany · Sales and marketing support
    15. Oxford Nanopore Technologies Gulf Limited 100% · United Arab Emirates · R&D and sales and marketing support
    16. Oxford Nanopore Technologies Holding Limited 100% · UK · Holding company
    17. Oxford Nanopore Technologies Holdings 2 Limited 100% · UK · Holding company
    18. Oxford Nanopore Technologies Canada Limited 100% · Canada · Limited risk distributor
    19. Northern Nanopore Instruments Inc. 100% · Italy · R&D support
    20. Oxford Nanopore Technologies India Private Limited 100% · India · Sales and marketing support
    21. Oxford Nanopore Technologies Middle East FZ LLC 100% · United Arab Emirates · Sales and marketing support

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

10 active · 22 resigned

Name Role Appointed Born Nationality
COOTE, Hannah Laura Secretary 2021-04-12
FORTUNE, Sarah Merritt, Dr Director 2023-12-19 Jul 1968 American
HENNAH, Adrian Nevil Director 2021-06-24 Nov 1957 British
KEHER, Nicholas Patrick Director 2024-01-22 Dec 1982 British
MAHONY, Daniel, Dr Director 2024-10-01 Mar 1969 British
O'HIGGINS, John Edward Director 2019-09-19 Feb 1964 Irish
PRESTON, Heather Elizabeth, Dr Director 2023-12-19 Jan 1966 British,Canadian
PRIESTMAN, Katherine Sophie Director 2023-07-13 Nov 1973 British
TATTON-BROWN, Duncan Eden Director 2022-08-01 Mar 1965 British
VAN PARYS, Francis Albert Luc Director 2026-03-02 May 1975 Belgian
Show 22 resigned officers
Name Role Appointed Resigned
@UKPLC CLIENT SECRETARY LTD Corporate Nominee Secretary 2005-03-09 2005-04-14
ALDWYCH SECRETARIES LIMITED Corporate Secretary 2005-04-14 2021-04-23
ALLEN, Peter Vance Director 2011-04-18 2022-07-31
AUBREY, Alan John Director 2009-03-03 2021-10-05
BAYLEY, John Hagan Pryce, Professor Director 2005-05-11 2016-01-01
BECKER, Wendy Mira Director 2021-06-24 2024-06-10
BROOKE, Stephen Henry Ralph Director 2005-05-20 2006-05-24
BROWN, Clive Gavin Director 2019-09-19 2024-02-29
BROWN, Clive Gavin Director 2017-09-20 2018-01-25
COWPER, Timothy Director 2018-12-13 2024-06-10
GORDON WILD, Sarah Lucinda Director 2015-01-01 2023-12-19
HARMELIN, Guy, Dr Director 2020-09-17 2024-10-01
MCDONALD, James Angus Director 2010-05-19 2018-12-13
NICHOLLS, Trevor John, Dr Director 2006-10-18 2012-05-31
NORWOOD, David Robert Director 2006-04-12 2008-12-31
PIGLIUCCI, Riccardo Director 2006-11-20 2011-06-15
SANGHERA, Gurdial Singh, Dr Director 2005-05-23 2026-03-02
SEITZ, Bernhard, Dr Director 2005-07-19 2006-08-01
THOMAS, Emma Claire Franklin Director 2005-04-14 2005-05-12
TRINIMAN, Paul Director 2005-08-01 2009-03-14
WILLCOCKS, James Peter, Dr Director 2006-05-24 2024-06-10
@UKPLC CLIENT DIRECTOR LTD Corporate Nominee Director 2005-03-09 2005-04-14

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 536 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-07-10 RESOLUTIONS Resolution
Date Type Category Description
2026-05-11 SH01 capital Capital allotment shares PDF
2026-04-13 SH01 capital Capital allotment shares PDF
2026-03-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-03-20 SH01 capital Capital allotment shares PDF
2026-03-13 AP01 officers Appoint person director company with name date PDF
2026-03-11 TM01 officers Termination director company with name termination date PDF
2026-03-06 SH01 capital Capital allotment shares PDF
2026-02-13 SH01 capital Capital allotment shares PDF
2026-01-26 SH01 capital Capital allotment shares PDF
2026-01-12 SH01 capital Capital allotment shares PDF
2025-12-29 SH01 capital Capital allotment shares PDF
2025-11-21 SH01 capital Capital allotment shares PDF
2025-11-14 SH01 capital Capital allotment shares PDF
2025-11-05 SH01 capital Capital allotment shares PDF
2025-10-08 SH01 capital Capital allotment shares PDF
2025-09-26 SH01 capital Capital allotment shares PDF
2025-09-03 SH01 capital Capital allotment shares PDF
2025-08-15 SH01 capital Capital allotment shares PDF
2025-07-18 SH01 capital Capital allotment shares PDF
2025-07-10 RESOLUTIONS resolution Resolution

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
20

last 12 months

Capital events
16

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page